Journal profile · Medicine-Health Policy
Journal of Cancer Policy
ISSN 2213-5383 · Elsevier
Journal of Cancer Policy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.2 (journal website); hybrid open access; APC about USD 2,760; median 93 days to acceptance (102 articles, last 24 months); 140 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Cancer Policy is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Economic and Financial Impacts of Cancer and Health Systems, Economic Evaluations, Quality of Life, together about 48.3% of its articles. Its main subfields are Oncology and Economics and Econometrics. (generated from OpenAlex topic counts and CAS ranking data)
In affiliation with European Cancer Organisation Journal of Cancer Policy invites all readers to join the dedicated Twitter channel for the journal: https://twitter.com/jcan_policyThe Journal of Cancer Policy is an international journal which publishes research and reviews on global cancer policy. The journal encompasses all aspects of cancer policy from prevention and public health through all modalities of control and cure, palliative care and survivorship including:* Cancer systems and services research * Cancer economics and value-based care * Inequalities in access and outcomes of cancer care * Development and regulatory issues related to cancer drugs, radiotherapy and surgical technologies * Priorities for cancer policy development in low, middle and high income countries * Innovative strategies for prevention, screening and diagnosis of cancer * Development of cancer research and education infrastructure * Social determinants of cancer * The role of trade, globalisation and the law in cancer control * The role of the media and patient advocacy in cancer policy * Policy and social science research germane to cancer * Patient advocacy and information researchThe Journal of Cancer Policy will consider original research, reviews, short communications and reports, and correspondence for publication.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Health Policy
Editor-in-chief Pricivel Carrera CochranePublisher website
Editorial board by country: none in mainland China; most named United Kingdom 12, United States 7, Canada 5, India 2, Sweden 2 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine18.9%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance17%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance12.4%
- Advances in Oncology and RadiotherapyMedicine7.3%
- Cancer survivorship and careMedicine5.1%
- Cervical Cancer and HPV ResearchMedicine4.8%
- Colorectal Cancer Screening and DetectionMedicine3.7%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Policy & Services | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Health Policy & Services | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 2.9LetPub ·
- CiteScore (publisher)
- 2.9Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.68LetPub ·
- h-index
- 30OpenAlex ·
- i10-index
- 158OpenAlex ·
- 2-year mean citedness
- 1.69OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 37.67%LetPub ·
Volume
- Articles per year
- 103LetPub ·
Articles by year OpenAlex count · 788 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 110 | 54 | 31 |
| 2025 | 140 | 65 | 244 |
| 2024 | 90 | 43 | 300 |
| 2023 | 80 | 39 | 390 |
| 2022 | 57 | 36 | 568 |
| 2021 | 51 | 23 | 504 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
93 daysMedian, submission to acceptance · P25–P75 68 days – 138 days
- Acceptance to online
- median 2 days (102 articles)
- Submission to online
- median 99 days
- Sample
- 102 articles with submission and acceptance dates (274 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 13 daysPublisher website ·
- First decision after review
- 71 daysPublisher website ·
- Submission to acceptance
- 73 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,760 / EUR 2,580 / GBP 2,210 / JPY 342,320 | — | — | |
| Publisher website | USD 3,060 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted8, with length limits
- correspondenceResearch Articles: Research articles which have not been published previously, except in a preliminary form, may be submitted as original full length research p…Length not stated
- letterResearch Articles: Research articles which have not been published previously, except in a preliminary form, may be submitted as original full length research p…main text ≤ 1,000 words
- policy analysisPolicy Analysis: Policy Analysis must contain a unstructured abstract of 250 words. Maximum word count of 2500. No more than 20 references.Length not stated
- research articleResearch Articles: Research articles which have not been published previously, except in a preliminary form, may be submitted as original full length research p…Length not stated
- research articlesResearch Articles: Research articles which have not been published previously, except in a preliminary form, may be submitted as original full length research p…Length not stated
- research paperResearch Articles: Research articles which have not been published previously, except in a preliminary form, may be submitted as original full length research p…Length not stated
- review articleResearch Articles: Research articles which have not been published previously, except in a preliminary form, may be submitted as original full length research p…Length not stated
- review articlesReview Articles: Review articles must contain an structured abstract (introduction, methods, results, policy summary), a list of up to ten keywords, and are lim…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2213-5383
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Cancer Policy
What CAS zone is Journal of Cancer Policy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cancer Policy is in Zone 4 of Medicine, and in Zone 4 of the minor category Health Policy & Services. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cancer Policy?
The journal's website gives an impact factor of 2.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.9, h-index 30.
How long does peer review take at Journal of Cancer Policy?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 68–138 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Cancer Policy?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Cancer Policy based?
Of the 36 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (12), United States (7) and Canada (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cancer Policy?
According to LetPub and DOAJ records, Journal of Cancer Policy is indexed in ESCI and Scopus.
Is Journal of Cancer Policy open access, and what is the APC?
Journal of Cancer Policy is a hybrid journal. For open-access publication: APC about USD 2,760.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .